SynVent is Syngene’s platform for fully integrated therapeutic discovery and development across large and small molecules.Â
Emerging biopharma work at the forefront of science, often venturing into disease areas where little or no real-world data exists to work with or regulatory frameworks to work within.
Our Dedicated Centers offer dedicated multi-disciplinary scientific teams, support personnel, and a tailormade ring-fenced and fire-walled infrastructure as per client specifications to support their  R&D  goals
Centre for Advanced Protein Studies [CAPS] is a state-of-the-art advanced national facility located in the Syngene campus, Bangalore.
Customer-centric pharma project management software for CRDMO programs—integrating metrics, feedback, and risk on one platform to deliver with speed and quality.
Syngene’s translational research speeds drug discovery and development and enables personalized medicine with robust models and biomarkers. Explore the approach.
